Sökning: "Cardiovascular mortality"
Visar resultat 16 - 20 av 685 avhandlingar innehållade orden Cardiovascular mortality.
16. Work-related cardiovascular disease
Sammanfattning : The overall aim of this thesis was to study occupational risk factors for cardiovascular disease, particularly, occupational noise, job strain and shift work. Incidence of cardiovascular disease was analysed in a general population sample, the Primary Prevention Study, in relation to exposure to noise and job strain. LÄS MER
17. Renal Dysfunction and Cardiovascular Disease
Sammanfattning : Kidney dysfunction increases cardiovascular disease (CVD) risk. The mechanisms for the risk increase seem to involve a combination of traditional and non-traditional CVD risk factors.We studied renal dysfunction as CVD and mortality risk factor in middle-aged men free from diabetes and CVD. LÄS MER
18. Oral health and cardiovascular disease
Sammanfattning : In the past two decades studies have indicated that oral health might be associated with the prevalence for cardiovascular disease (CVD), although the biological link still remains unknown. Bacteria and inflammatory mediators causing periodontal disease have also been suggested to influence the progression of atherosclerosis. LÄS MER
19. Cathepsin S as a Biomarker of Low-grade Inflammation, Insulin Resistance, and Cardiometabolic Disease Risk
Sammanfattning : Cathepsin S is a protease important in major histocompatibility complex (MHC) class II antigen presentation and also in degrading the extracellular matrix. Studies, most of them experimental, have shown that cathepsin S is involved in different pathological conditions such as obesity, inflammation, atherosclerosis, diabetes, and cancer. LÄS MER
20. Adherence to lipid-lowering medications and cardiovascular disease prevention in type 2 diabetes mellitus
Sammanfattning : Background and aims: Globally, cardiovascular disease (CVD) is the major cause of death among patients with type 2 diabetes mellitus (T2DM). Improved control of LDL cholesterol with lipid-lowering medications and patients’ adherence to such medications have been shown associate with lower risk of CV events and mortality among T2DM patients. LÄS MER